Oxelumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | OX-40 ligand |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number |
|
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6424H9920N1704O2014S42 |
Molar mass | 144594.46 g·mol−1 |
(what is this?) |
Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]
Oxelumab was developed by Genentech and co-developed by Roche.
References[]
Categories:
- Drugs not assigned an ATC code
- Hoffmann-La Roche brands
- Genentech brands
- Experimental drugs
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs